Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) — Stock Price

Rs232.97 INR
▲ 0.76% today

Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) is currently trading at Rs232.97 INR, up 0.76% today. Over the past 52 weeks, shares have ranged between Rs161.07 and Rs251.05. This page tracks Jagsonpal Pharmaceuticals Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Jagsonpal Pharmaceuticals Limited market capitalisation.

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Jagsonpal Pharmaceuticals Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Jagsonpal Pharmaceuticals Limited Income Statement — Revenue, Profit & Earnings by Year

Jagsonpal Pharmaceuticals Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Rs2.69 Billion Rs2.09 Billion Rs2.37 Billion Rs2.18 Billion Rs1.88 Billion
Cost of Revenue Rs964.38 Million Rs1.43 Billion Rs931.04 Million Rs961.06 Million Rs809.34 Million
Gross Profit Rs1.72 Billion Rs652.59 Million Rs1.44 Billion Rs1.28 Billion Rs1.07 Billion
Research & Development — — — — Rs3.46 Million
SG&A Rs713.59 Million Rs38.05 Million Rs57.64 Million Rs101.73 Million Rs40.69 Million
Total Operating Expenses Rs709.33 Million Rs438.55 Million Rs1.10 Billion Rs1.04 Billion Rs662.18 Million
Operating Income Rs435.49 Million Rs214.04 Million Rs343.30 Million Rs245.45 Million Rs187.86 Million
EBITDA Rs510.71 Million Rs323.46 Million Rs363.96 Million Rs284.53 Million Rs234.72 Million
EBIT Rs429.40 Million Rs306.83 Million Rs352.21 Million Rs269.27 Million Rs223.86 Million
Interest Expense Rs9.58 Million Rs8.14 Million Rs4.13 Million Rs2.85 Million Rs5.13 Million
Income Before Tax Rs698.59 Million Rs298.69 Million Rs348.08 Million Rs266.42 Million Rs218.72 Million
Income Tax Expense Rs144.98 Million Rs74.06 Million Rs80.87 Million Rs77.87 Million Rs48.14 Million
Net Income Rs553.61 Million Rs224.63 Million Rs267.21 Million Rs188.55 Million Rs170.58 Million

Jagsonpal Pharmaceuticals Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Jagsonpal Pharmaceuticals Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Rs2.78 Billion Rs2.17 Billion Rs1.95 Billion Rs1.68 Billion Rs1.64 Billion
Total Current Assets Rs1.61 Billion Rs1.99 Billion Rs1.65 Billion Rs1.09 Billion Rs1.20 Billion
Cash & Equivalents — — Rs110.53 Million Rs232.33 Million Rs589.43 Million
Short-term Investments Rs1.18 Billion Rs1.35 Billion Rs1.04 Billion Rs245.31 Million Rs32.51 Million
Net Receivables Rs131.76 Million Rs109.51 Million Rs208.72 Million Rs165.89 Million Rs142.19 Million
Inventory Rs152.00 Million Rs149.97 Million Rs206.76 Million Rs297.42 Million Rs297.25 Million
Property, Plant & Equipment Rs847.61 Million Rs93.02 Million Rs242.78 Million Rs223.73 Million Rs233.47 Million
Goodwill Rs96.93 Million Rs0.00 Rs0.00 Rs300.00K Rs300.00K
Total Liabilities Rs383.10 Million Rs296.76 Million Rs360.56 Million Rs375.99 Million Rs422.73 Million
Total Current Liabilities Rs259.04 Million Rs191.28 Million Rs275.72 Million Rs269.72 Million Rs403.97 Million
Long-term Debt — — — Rs12.56 Million Rs180.00K
Net Debt Rs-1.19 Billion Rs-38.19 Million Rs-50.52 Million Rs-251.35 Million Rs-550.94 Million
Total Stockholder Equity Rs2.40 Billion Rs1.87 Billion Rs1.59 Billion Rs1.31 Billion Rs1.22 Billion
Retained Earnings Rs1.49 Billion Rs1.04 Billion Rs945.37 Million Rs675.15 Million Rs1.00 Billion

Jagsonpal Pharmaceuticals Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Jagsonpal Pharmaceuticals Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Rs553.00 Million Rs351.66 Million Rs466.54 Million Rs55.98 Million Rs282.22 Million
Capital Expenditures Rs3.48 Million Rs2.48 Million Rs3.18 Million Rs4.67 Million Rs4.69 Million
Free Cash Flow Rs549.52 Million Rs349.18 Million Rs463.37 Million Rs51.31 Million Rs277.53 Million
Investing Cash Flow Rs-451.47 Million Rs-245.48 Million Rs-576.71 Million Rs-262.08 Million Rs-22.64 Million
Financing Cash Flow Rs-116.98 Million Rs-89.11 Million Rs-4.57 Million Rs-123.04 Million Rs-68.28 Million
Dividends Paid Rs-132.29 Million Rs-130.99 Million Rs0.00 Rs104.79 Million Rs26.20 Million
Stock-Based Compensation Rs68.04 Million Rs133.10 Million Rs87.65 Million Rs87.65 Million —
Depreciation Rs81.31 Million Rs16.63 Million Rs12.05 Million Rs15.26 Million Rs10.86 Million
Change in Cash Rs-15.45 Million Rs17.07 Million Rs-114.73 Million Rs-329.14 Million Rs191.30 Million

Jagsonpal Pharmaceuticals Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Jagsonpal Pharmaceuticals Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 04, 2026 — — —
Jan 20, 2026 — — —
Oct 21, 2025 — — —
Aug 05, 2025 — — —
Jan 31, 2025 — — —